FDA warns of liver damage reports with Multag
Federal health officials are “warning doctors and patients that a recently launched heart drug from Sanofi-Aventis SA has been linked to liver damage in a handful of patients.” (Washington AP, 1/14). As a Chicago area personal injury attorney, I urge all consumers to consult medical professionals before using this drug.
Although the FDA approved the drug, Multag, in 2009 to treat irregular heart rhythms that can lead to stroke, after several reports of liver damage, including two cases where patients’ livers had to be removed, the Food and Drug Administration issued the warning warning.
Currently, the FDA plans to add further warning labels about the risk of liver injury, and encourages patients taking Multag who experience nausea, vomiting and fever, to contact their doctor immediately.
Bookmark: 
